XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 482 $ 1,566
Accounts receivable, net of allowance of $988 and $1,674, respectively 129,306 137,544
Inventory 87,942 84,622
Other current assets 7,147 8,228
Total current assets 224,877 231,960
Property, plant and equipment, net 2,302,417 2,199,253
Operating lease right-of-use assets 14,866 16,706
Intangible assets, net 31,681 37,077
Contract costs, net 37,954 34,736
Deferred tax assets 10,984 33,353
Other assets 41,463 37,079
Non-current assets of discontinued operations 7,868 8,586
Total assets 2,672,110 2,598,750
Current liabilities:    
Accounts payable, trade 52,000 64,324
Accrued liabilities 101,101 76,915
Deferred revenue 6,274 7,332
Total current liabilities 159,375 148,571
Long-term debt 1,604,554 1,548,334
Operating lease liabilities 12,928 14,861
Deferred tax liabilities 1,418 854
Other liabilities 24,874 17,569
Non-current liabilities of discontinued operations 7,868 7,868
Total liabilities 1,811,017 1,738,057
Commitments and contingencies (Note 7)
Equity:    
Preferred stock: $0.01 par value per share, 50,000,000 shares authorized, zero issued
Common stock: $0.01 par value per share, 250,000,000 shares authorized, 164,959,743 and 163,439,013 shares issued, respectively 1,649 1,634
Additional paid-in capital 3,467,051 3,456,777
Accumulated deficit (2,508,743) (2,509,133)
Treasury stock: 8,839,652 and 7,810,548 common shares, at cost, respectively (98,864) (88,585)
Total equity 861,093 860,693
Total liabilities and equity $ 2,672,110 $ 2,598,750